Omega Fund Management, LLC Trevi Therapeutics, Inc. Transaction History

Omega Fund Management, LLC

  • $67.4 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$0.68 - $1.5 $859,117 - $1.9 Million
-1,263,408 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$2.42 - $3.99 $272,247 - $448,871
-112,499 Reduced 8.18%
1,263,408 $3.33 Million
Q2 2020

Aug 17, 2020
BUY
$2.51 - $6.87 $282,372 - $772,868
112,499 Added 8.9%
1,375,907 $9.05 Million
Q2 2019

Aug 13, 2019
BUY
$7.5 - $10.12 $9.48 Million - $12.8 Million
1,263,408 New
1,263,408 $9.48 Million

Others Institutions Holding TRVI

# of Institutions
94
Shares Held
57.1M
Call Options Held
136K
Put Options Held
5.4K
View Full List

About Trevi Therapeutics, Inc.

TRVI Quotes by TradingView
  • Ticker TRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,322,500
  • Market Cap $162M
  • Description
  • Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...
More about TRVI
Track This Portfolio

Track Omega Fund Management, LLC Portfolio

Follow Omega Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omega Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Omega Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email